Stocks
Funds
Screener
Sectors
Watchlists
NRC

NRC - National Research Corp Stock Price, Fair Value and News

$16.51+0.01 (+0.06%)
Delayed

24/100

NRC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

24/100

NRC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NRC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NRC Price Action

Last 7 days

13.2%

Last 30 days

20.1%

Last 90 days

-6.4%

Trailing 12 Months

13.2%

NRC RSI Chart

NRC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NRC Valuation

Market Cap

375.5M

Price/Earnings (Trailing)

32.37

Price/Sales (Trailing)

2.73

EV/EBITDA

12.4

Price/Free Cashflow

23.85

NRC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NRC Fundamentals

NRC Revenue

Revenue (TTM)

137.4M

Rev. Growth (Yr)

-4.64%

Rev. Growth (Qtr)

1.69%

NRC Earnings

Earnings (TTM)

11.6M

Earnings Growth (Yr)

-72.6%

Earnings Growth (Qtr)

-56.39%

NRC Profitability

EBT Margin

12.99%

Return on Equity

82.92%

Return on Assets

8.6%

Free Cashflow Yield

4.19%

NRC Investor Care

Dividend Yield

3.15%

Dividend/Share (TTM)

0.52

Buy Backs (1Y)

0.87%

Diluted EPS (TTM)

50

NRC Alerts

  • 1 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025141.3M140.3M139.1M137.4M
2024147.4M146.3M144.2M143.1M
2023149.6M148.5M148.7M148.6M
2022150.9M151.8M151.7M151.6M
2021134.9M140.1M144.4M148.0M
2020130.4M130.1M131.1M133.3M
2019120.1M123.5M126.0M128.0M
2018118.3M117.9M118.9M119.7M
2017111.8M114.1M116.0M117.6M
2016103.9M105.6M107.4M109.4M
201599.1M99.5M101.1M102.3M
201493.7M95.4M96.6M98.8M
201388.9M90.6M91.7M92.6M
201278.4M80.7M83.5M86.4M
201165.8M70.0M72.5M75.8M
NRC
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
 CEO
 WEBSITEnrchealth.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES491

National Research Corp Frequently Asked Questions


NRC is the stock ticker symbol of National Research Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of National Research Corp is 375.54 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, NRC's PE ratio (Price to Earnings) is 32.37 and Price to Sales (PS) ratio is 2.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NRC PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, National Research Corp has provided 0.013 (multiply by 100 for percentage) rate of return.